For relevant product configurations (i.e., standalone device configurations) we also provide a tailored clinical strategy and evidence generation, including Clinical Evaluation Plans (CEP) and Reports (CER), designed to support regulatory submissions.
We facilitate comprehensive hazard analysis, Failure Mode and Effects Analysis (FMEA), and robust risk control measures to ensure patient safety and adherence to ISO 14971.
We develop Clinical Evaluation Plans (CEP) and Reports (CER) for standalone medical devices, ensuring your clinical evidence is both scientifically sound and ready for regulatory scrutiny.
We bridge the gap between risk management files and clinical documentation, ensuring traceability and consistent messaging across all your submission dossiers.
From initial design inputs through to post-market surveillance, we provide the technical expertise to maintain your risk-benefit profile and ensure your clinical evidence stays current with evolving global requirements.
Join over 100+ clients already trust Beyond Conception.
